Article
New acquisition : MImAbs & Beacon®
Berkeley Lights Debuts in France as MImAbs Acquires the Beacon® Optofluidic System for Antibody Discovery
Read the press release
Berkeley Lights Debuts in France as MImAbs Acquires the Beacon® Optofluidic System for Antibody Discovery
Contact MimAbs to discuss your project, our team will support you in the scientific study and strategic development planning of your project.
Contact an expert